News

MedUni Vienna: Cured hepatitis C with advanced liver disease: cancer risk remains

IMC Krems: Forschungsprojekt zur Entwicklung optogenetischer Stammzelllinien erfolgreich - "Lichtschalter" für spezielle Rezeptoren entwickelt

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

vetmeduni: Caripe 8: Wiener Forschungsteam identifiziert neuen Anti-Krebswirkstoff

LBI: MICSE guidelines published in “Cell” provide a universal toolset for cellular senescence in vivo research

QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform

AOP Health New Cancer Trial

MedUni Vienna: New method for diagnosing and monitoring COVID-19 severity

MedUni Vienna: Heart failure in type 2 diabetes: Current diagnostic methods unreliable in women

SAN Group ernennt neuen Chief Financial Officer sowie Chief Sales and Marketing Officer

MedUni Vienna: New insights into cellular processes after a stroke

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

Sandia National Laboratories acquire second Lithoz CeraFab printer to ramp up their R&D scale of additively manufactured ceramic parts

University of Vienna: The Next Generation of RNA Chips

ÖGP: Welt-Lungenkrebstag: „Zukunftsmusik“ spielt im Hier und Jetzt

MedUni Vienna: Gastric cancer - Biomarkers identified to predict the risk of relapse

MedUni Vienna: Climate change and "new" allergy triggers extend pollen season

Wiener Gesundheitsverbund und die Vinzenz Gruppe Wien setzen auf digitalen Bildaustausch

Pharmig: Lebenswichtig: Blutplasmaspenden werden dringend benötigt

Cancer Mission Lab des Open Innovation in Science Center der LBG: Förderempfehlung für drei innovative Projekte